Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 2 (JAK2), particularly in the development of treatments for myeloproliferative disorders. Shows promise in suppressing abnormal cell signaling pathways involved in blood-related cancers. Also investigated for anti-inflammatory applications due to its role in modulating cytokine signaling. Its structure allows for high target specificity, making it a valuable scaffold in optimizing kinase inhibitors with improved efficacy and reduced off-target effects.